Shuttle Pharmaceuticals Holdings, Inc. Finalizes Agreements for Phase 2 Clinical Trial Enrollment: Press Release Analysis
Shuttle Pharmaceuticals Holdings, Inc., a Delaware corporation trading as SHPH on the Nasdaq Stock Market LLC, recently announced significant progress in their clinical trial endeavors. On October 28, 2024, the company issued a press release detailing the completion of agreements with all six intended site enrollment locations for the administration of the Phase 2 clinical […]
More Stories
DOJ Opens Path to Restore Federal Gun Rights for 30 Million Americans
By Tom Gantert The Justice Department announced on Aug. 17 a new process that will allow eligible individuals prohibited from...
China Used Sex, Donations, Planted Interns to Influence US Political System: Declassified Docs
By Travis Gillmore WASHINGTON— Nearly 150 pages of newly declassified FBI documents paint the clearest picture yet of the relationship...
Apple Business Manager: Login Process, Features, Pricing, and More
Apple Business Manager is a free web-based portal that helps businesses to manage, or you can say organize, different Apple...
Hawaii’s Big Island Prepares as Lala Strengthens to Hurricane Ahead of Possible Landfall
By Jeremy Lott Tropical Storm Lala has strengthened to a hurricane and could be the first to make landfall over...
US Tells EU ‘Now It’s Time to Deliver’ on Trade Commitments
By Bill Pan The United States is urging the European Union to further ease its corporate environmental rules, citing commitments...
Iran Accuses Qatar of Holding 3 of Its Military Pilots Captive
By Ryan Morgan The Iranian military, on Aug. 15, claimed three of its pilots are currently being held by Qatar,...